Le Lézard
Classified in: Health
Subjects: MAV, VET, FVT, CFG

/R E P E A T -- Media Advisory - Minister MacAulay to make important announcement regarding the Veteran and Family Well-Being Fund/


CALGARY, Aug. 26, 2019 /CNW/ - The Honourable Lawrence MacAulay, Minister of Veterans Affairs and Associate Minister of National Defence, will make an important announcement that will positively impact the well-being of Veterans and their families in Canada.

Minister MacAulay along with other event participants will be available to media and for a photo opportunity following the announcement.

 

Location:

1010 Centre Street SE
Common Room (2nd level)
Calgary, AB



Date:

Tuesday, August 27, 2019



Time:

10:30 MDT

 

SOURCE Veterans Affairs Canada


These press releases may also interest you

at 03:00
Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities
Clarivate Plc , a leading global provider of transformative intelligence, today announced the release of the MedTech Trends to Watch 2024 report, the second installment in a two-part series offering a predictive analysis of emerging trends shaping...

at 02:59
Immunovia's new lab staffed and operational after rapid implementation
Immunovia (STOCKHOLM: IMMNOV), the diagnostics company seeking to increase pancreatic cancer survival through early detection, today offers an update on its new lab in Research Triangle Park, USA.  Immunovia announced on 29 April the company's...

at 02:23
Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout
Sobi® today announced the initiation of a rolling Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for SEL-212. The submission is based on the results of the DISSOLVE I and II pivotal studies. SEL-212 is an...

at 02:00
Menarini's cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw
Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the potential for an automated system to deliver genomic profiles of fetal cells that is highly concordant with the genomic analysis obtained from...

at 01:35
4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth
4Moving Biotech (4MB), a clinical-stage subsidiary of 4P-Pharma specializing in immuno-inflammation and osteoarthritis, is pleased to announce the appointment of Luc Boblet as Chief Executive Officer. The company, having successfully completed its...

at 01:00
Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroendocrine tumors based on positive CABINET Phase III trial
 Decision adds to existing collaboration agreement with Exelixis, permitting Ipsen to seek potential marketing authorizations for Cabometyx® (cabozantinib) in advanced pancreatic and extra pancreatic neuroendocrine tumors outside of the U.S. and...

More news about Health...


News published on and distributed by: